Abstract

APOBEC3A (A3A), one of the seven-member APOBEC3 family of cytidine deaminases, lacks strong antiviral activity against lentiviruses but is a potent inhibitor of adeno-associated virus and endogenous retroelements. In this report, we characterize the biochemical properties of mammalian cell-produced and catalytically active E. coli-produced A3A. The enzyme binds to single-stranded DNA with a Kd of 150 nM and forms dimeric and monomeric fractions. A3A, unlike APOBEC3G (A3G), deaminates DNA substrates nonprocessively. Using a panel of oligonucleotides that contained all possible trinucleotide contexts, we identified the preferred target sequence as TC (A/G). Based on a three-dimensional model of A3A, we identified a putative binding groove that contains residues with the potential to bind substrate DNA and to influence target sequence specificity. Taking advantage of the sequence similarity to the catalytic domain of A3G, we generated A3A/A3G chimeric proteins and analyzed their target site preference. We identified a recognition loop that altered A3A sequence specificity, broadening its target sequence preference. Mutation of amino acids in the predicted DNA binding groove prevented substrate binding, confirming the role of this groove in substrate binding. These findings shed light on how APOBEC3 proteins bind their substrate and determine which sites to deaminate.

Highlights

  • APOBEC3A (A3A) is one of the seven-member APOBEC3 family of cytidine deaminases encoded in the human genome [1,2,3]

  • A detailed analysis of deamination target site preference shows that the consensus deamination sequence for A3A is TC (A/G)

  • This finding is similar to the (T/C) CA consensus previously reported by Chen et al [41] and the TC identified by others [35,42]

Read more

Summary

Introduction

APOBEC3A (A3A) is one of the seven-member APOBEC3 family of cytidine deaminases encoded in the human genome [1,2,3]. The protein has potent cytidine deaminase activity but unlike other family members, such as APOBEC3F (A3F) and APOBEC3G (A3G), does not appear to have considerable activity against HIV-1. Given A3A cytidine deaminase activity and its ability to be packaged, it is unclear why it lacks antiviral activity. Fusion of A3A to Vpr or the N-terminus of A3G activates the antiviral activity of the protein, perhaps by causing it to associate more tightly with the virion core [22,23]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.